1
|
Wu X, Daniel Ulumben A, Long S, Katagiri W, Wilks MQ, Yuan H, Cortese B, Yang C, Kashiwagi S, Choi HS, Normandin MD, El Fakhri G, Zaman RT. Near-Infrared Fluorescence Imaging of Carotid Plaques in an Atherosclerotic Murine Model. Biomolecules 2021; 11:1753. [PMID: 34944397 PMCID: PMC8698491 DOI: 10.3390/biom11121753] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/19/2021] [Revised: 11/11/2021] [Accepted: 11/17/2021] [Indexed: 12/26/2022] Open
Abstract
Successful imaging of atherosclerosis, one of the leading global causes of death, is crucial for diagnosis and intervention. Near-infrared fluorescence (NIRF) imaging has been widely adopted along with multimodal/hybrid imaging systems for plaque detection. We evaluate two macrophage-targeting fluorescent tracers for NIRF imaging (TLR4-ZW800-1C and Feraheme-Alexa Fluor 750) in an atherosclerotic murine cohort, where the left carotid artery (LCA) is ligated to cause stenosis, and the right carotid artery (RCA) is used as a control. Imaging performed on dissected tissues revealed that both tracers had high uptake in the diseased vessel compared to the control, which was readily visible even at short exposure times. In addition, ZW800-1C's renal clearance ability and Feraheme's FDA approval puts these two tracers in line with other NIRF tracers such as ICG. Continued investigation with these tracers using intravascular NIRF imaging and larger animal models is warranted for clinical translation.
Collapse
Affiliation(s)
- Xiaotian Wu
- Gordon Center for Medical Imaging, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA; (A.D.U.); (W.K.); (M.Q.W.); (H.Y.); (B.C.); (C.Y.); (S.K.); (H.S.C.); (M.D.N.); (G.E.F.); (R.T.Z.)
| | - Amy Daniel Ulumben
- Gordon Center for Medical Imaging, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA; (A.D.U.); (W.K.); (M.Q.W.); (H.Y.); (B.C.); (C.Y.); (S.K.); (H.S.C.); (M.D.N.); (G.E.F.); (R.T.Z.)
| | - Steven Long
- Department of Pathology, University of California, San Francisco, CA 94143, USA;
| | - Wataru Katagiri
- Gordon Center for Medical Imaging, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA; (A.D.U.); (W.K.); (M.Q.W.); (H.Y.); (B.C.); (C.Y.); (S.K.); (H.S.C.); (M.D.N.); (G.E.F.); (R.T.Z.)
| | - Moses Q. Wilks
- Gordon Center for Medical Imaging, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA; (A.D.U.); (W.K.); (M.Q.W.); (H.Y.); (B.C.); (C.Y.); (S.K.); (H.S.C.); (M.D.N.); (G.E.F.); (R.T.Z.)
| | - Hushan Yuan
- Gordon Center for Medical Imaging, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA; (A.D.U.); (W.K.); (M.Q.W.); (H.Y.); (B.C.); (C.Y.); (S.K.); (H.S.C.); (M.D.N.); (G.E.F.); (R.T.Z.)
| | - Brian Cortese
- Gordon Center for Medical Imaging, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA; (A.D.U.); (W.K.); (M.Q.W.); (H.Y.); (B.C.); (C.Y.); (S.K.); (H.S.C.); (M.D.N.); (G.E.F.); (R.T.Z.)
| | - Chengeng Yang
- Gordon Center for Medical Imaging, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA; (A.D.U.); (W.K.); (M.Q.W.); (H.Y.); (B.C.); (C.Y.); (S.K.); (H.S.C.); (M.D.N.); (G.E.F.); (R.T.Z.)
| | - Satoshi Kashiwagi
- Gordon Center for Medical Imaging, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA; (A.D.U.); (W.K.); (M.Q.W.); (H.Y.); (B.C.); (C.Y.); (S.K.); (H.S.C.); (M.D.N.); (G.E.F.); (R.T.Z.)
| | - Hak Soo Choi
- Gordon Center for Medical Imaging, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA; (A.D.U.); (W.K.); (M.Q.W.); (H.Y.); (B.C.); (C.Y.); (S.K.); (H.S.C.); (M.D.N.); (G.E.F.); (R.T.Z.)
| | - Marc D. Normandin
- Gordon Center for Medical Imaging, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA; (A.D.U.); (W.K.); (M.Q.W.); (H.Y.); (B.C.); (C.Y.); (S.K.); (H.S.C.); (M.D.N.); (G.E.F.); (R.T.Z.)
| | - Georges El Fakhri
- Gordon Center for Medical Imaging, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA; (A.D.U.); (W.K.); (M.Q.W.); (H.Y.); (B.C.); (C.Y.); (S.K.); (H.S.C.); (M.D.N.); (G.E.F.); (R.T.Z.)
| | - Raiyan T. Zaman
- Gordon Center for Medical Imaging, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA; (A.D.U.); (W.K.); (M.Q.W.); (H.Y.); (B.C.); (C.Y.); (S.K.); (H.S.C.); (M.D.N.); (G.E.F.); (R.T.Z.)
| |
Collapse
|
2
|
Sun S, Błażewska KM, Kadina AP, Kashemirov BA, Duan X, Triffitt JT, Dunford JE, Russell RGG, Ebetino FH, Roelofs AJ, Coxon FP, Lundy MW, McKenna CE. Fluorescent Bisphosphonate and Carboxyphosphonate Probes: A Versatile Imaging Toolkit for Applications in Bone Biology and Biomedicine. Bioconjug Chem 2015; 27:329-40. [PMID: 26646666 DOI: 10.1021/acs.bioconjchem.5b00369] [Citation(s) in RCA: 41] [Impact Index Per Article: 4.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/24/2022]
Abstract
A bone imaging toolkit of 21 fluorescent probes with variable spectroscopic properties, bone mineral binding affinities, and antiprenylation activities has been created, including a novel linking strategy. The linking chemistry allows attachment of a diverse selection of dyes fluorescent in the visible to near-infrared range to any of the three clinically important heterocyclic bisphosphonate bone drugs (risedronate, zoledronate, and minodronate or their analogues). The resultant suite of conjugates offers multiple options to "mix and match" parent drug structure, fluorescence emission wavelength, relative bone affinity, and presence or absence of antiprenylation activity, for bone-related imaging applications.
Collapse
Affiliation(s)
- Shuting Sun
- Department of Chemistry, University of Southern California , Los Angeles, California 90089, United States.,BioVinc LLC , 6162 Bristol Parkway, Culver City, California 90230, United States
| | - Katarzyna M Błażewska
- Department of Chemistry, University of Southern California , Los Angeles, California 90089, United States.,Faculty of Chemistry, Lodz University of Technology , Zeromskiego 116, 90-924 Lodz, Poland
| | - Anastasia P Kadina
- Department of Chemistry, University of Southern California , Los Angeles, California 90089, United States
| | - Boris A Kashemirov
- Department of Chemistry, University of Southern California , Los Angeles, California 90089, United States
| | - Xuchen Duan
- Botnar Research Centre, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford , Nuffield Orthopaedic Centre, Oxford, OX3 7LD, United Kingdom
| | - James T Triffitt
- Botnar Research Centre, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford , Nuffield Orthopaedic Centre, Oxford, OX3 7LD, United Kingdom
| | - James E Dunford
- Botnar Research Centre, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford , Nuffield Orthopaedic Centre, Oxford, OX3 7LD, United Kingdom
| | - R Graham G Russell
- Botnar Research Centre, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford , Nuffield Orthopaedic Centre, Oxford, OX3 7LD, United Kingdom
| | - Frank H Ebetino
- BioVinc LLC , 6162 Bristol Parkway, Culver City, California 90230, United States
| | - Anke J Roelofs
- Musculoskeletal Research Programme, Institute of Medical Sciences, University of Aberdeen , Aberdeen, AB25 2ZD, United Kingdom
| | - Fraser P Coxon
- Musculoskeletal Research Programme, Institute of Medical Sciences, University of Aberdeen , Aberdeen, AB25 2ZD, United Kingdom
| | - Mark W Lundy
- BioVinc LLC , 6162 Bristol Parkway, Culver City, California 90230, United States
| | - Charles E McKenna
- Department of Chemistry, University of Southern California , Los Angeles, California 90089, United States
| |
Collapse
|
3
|
Douma K, Megens RTA, van Zandvoort MAMJ. Optical molecular imaging of atherosclerosis using nanoparticles: shedding new light on the darkness. WILEY INTERDISCIPLINARY REVIEWS-NANOMEDICINE AND NANOBIOTECHNOLOGY 2011; 3:376-88. [DOI: 10.1002/wnan.139] [Citation(s) in RCA: 24] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
Affiliation(s)
- Kim Douma
- Department of Biomedical Engineering, Maastricht University Medical Centre, Maastricht, The Netherlands
- Department of Radiology, Maastricht University Medical Centre, Maastricht, The Netherlands
- Cardiovascular Research Institute Maastricht (CARIM), Maastricht University Medical Centre, Maastricht, The Netherlands
| | - Remco T. A. Megens
- Institute for Cardiovascular Prevention, Ludwig‐Maximilians‐University, Munich, Germany
- Institute for Molecular Cardiovascular Research (IMCAR), Interdisciplinary Centre for Clinical Research, RWTH Aachen University, Aachen, Germany
| | - Marc A. M. J. van Zandvoort
- Department of Biomedical Engineering, Maastricht University Medical Centre, Maastricht, The Netherlands
- Cardiovascular Research Institute Maastricht (CARIM), Maastricht University Medical Centre, Maastricht, The Netherlands
- Institute for Molecular Cardiovascular Research (IMCAR), Interdisciplinary Centre for Clinical Research, RWTH Aachen University, Aachen, Germany
| |
Collapse
|